Abstract
Despite progress in blood culture media and automated growth detection systems, blood culture-negative endocarditis (BCNE) still represents 5–69.7 % of all endocarditis cases. Under the BCNE acronym are grouped diverse clinical entities: (i) the most common are cases of bacterial endocarditis caused by usual pathogens in which the negativity of blood cultures is explained by the early antibiotic treatment started prior to blood sampling; (ii) endocarditis caused by fastidious microorganisms that require prolonged incubation and/or specific media, including Brucella sp., defective streptococci (Abiotrophia sp., Gemella sp.), HACEK bacteria, Propionibacterium acnes, fungi; (iii) endocarditis caused by strictly (Coxiella burnetii, Tropheryma whipplei) or facultative (Bartonella sp.) intracellular bacteria; and (iv) endocarditis that complicate cancers (marantic endocarditis), auto-immune diseases (lupus, Behçet, rheumatoid arthritis) or allergy to pork. Various diagnostic strategies, combining systematic serological, molecular, biochemical and/or histological assays, have improved the diagnostic yield of BCNE but this condition remains challenging.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Martin JM, Neches WH, Wald ER. Infective endocarditis: 35 years of experience at a children’s hospital. Clin Infect Dis. 1997;24:669–75.
Sandre RM, Shafran SD. Infective endocarditis: review of 135 cases over 9 years. Clin Infect Dis. 1996;22:276–86.
Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler Jr VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169(5):463–73.
Moreillon P, Que YA. Infective endocarditis. Lancet. 2004;363(9403):139–49.
Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, et al. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol. 2005;43(10):5238–42.
Li JS, Sexton DJ, Mick N, Nettles R, Fowler VGJ, Ryan T, et al. Proposed modifications to the duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633–8.
Fournier PE, Thuny F, Richet H, Lepidi H, Casalta JP, Arzouni JP, et al. Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases. Clin Infect Dis. 2010;51(2):131–40.
Fournier PE, Thuny F, Grisoli D, Lepidi H, Vitte J, Casalta JP, et al. A deadly aversion to pork. Lancet. 2011;377(9776):1542.
Murashita T, Sugiki H, Kamikubo Y, Yasuda K. Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes. Eur J Cardiothorac Surg. 2004;26(6):1104–11.
Zamorano J, Sanz J, Almeria C, Rodrigo JL, Samedi M, Herrera D, et al. Differences between endocarditis with true negative blood cultures and those with previous antibiotic treatment. J Heart Valve Dis. 2003;12(2):256–60.
Zamorano J, Sanz J, Moreno R, Almeria C, Rodrigo JL, Samedi M, et al. Comparison of outcome in patients with culture-negative versus culture-positive active infective endocarditis. Am J Cardiol. 2001;87(12):1423–5.
Chambers J, Sandoe J, Ray S, Prendergast B, Taggart D, Westaby S, et al. The infective endocarditis team: recommendations from an international working group. Heart. 2014;100(7):524–7.
Botelho-Nevers E, Thuny F, Casalta JP, Richet H, Gouriet F, Collart F, et al. Dramatic reduction in infective endocarditis-related mortality with a management-based approach. Arch Intern Med. 2009;169(14):1290–8.
Werner M, Andersson R, Olaison L, Hogevik H. A 10-year survey of blood culture negative endocarditis in Sweden: aminoglycoside therapy is important for survival. Scand J Infect Dis. 2008;40(4):279–85.
Benslimani A, Fenollar F, Lepidi H, Raoult D. Bacterial zoonoses and infective endocarditis, Algeria. Emerg Infect Dis. 2005;11(2):216–24.
Koegelenberg CF, Doubell AF, Orth H, Reuter H. Infective endocarditis in the Western Cape Province of South Africa: a three-year prospective study. QJM. 2003;96(3):217–25.
Tariq M, Alam M, Munir G, Khan MA, Smego Jr RA. Infective endocarditis: a five-year experience at a tertiary care hospital in Pakistan. Int J Infect Dis. 2004;8(3):163–70.
Marks P, Gogova M, Kromery VJR. Culture negative endocarditis: data from the national survey in Slovakia. Postgrad Med J. 2002;78:61–2.
Lamas CC, Eykyn SJ. Blood culture negative endocarditis: analysis of 63 cases presenting over 25 years. Heart. 2003;89(3):258–62.
Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J. 2003;67(11):901–5.
Ferrera C, Vilacosta I, Fernandez C, Lopez J, Olmos C, Sarria C, et al. Reassessment of blood culture-negative endocarditis: its profile is similar to that of blood culture-positive endocarditis. Rev Esp Cardiol (Engl Ed). 2012;65(10):891–900.
Brouqui P, Raoult D. New insight into the diagnosis of fastidious bacterial endocarditis. FEMS Immunol Med Microbiol. 2006;47(1):1–13.
Selton-Suty C, Celard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, et al. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54(9):1230–9.
Hoen B, Selton-Suty C, Lacassin F, Etienne J, Briançon S, Leport C, et al. Infective endocarditis in patients with negative blood cultures: analysis of 88 cases from a one-year nationwide survey in France. Clin Infect Dis. 1995;20:501–6.
Cecchi E, Forno D, Imazio M, Migliardi A, Gnavi R, Dal Conte I, et al. New trends in the epidemiological and clinical features of infective endocarditis: results of a multicenter prospective study. Ital Heart J. 2004;5(4):249–56.
Siciliano RF, Mansur AJ, Castelli JB, Arias V, Grinberg M, Levison ME, et al. Community-acquired culture-negative endocarditis: clinical characteristics and risk factors for mortality. Int J Infect Dis. 2014;25:191–5.
Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. Int J Cardiol. 2005;98(2):253–60.
Cetinkaya Y, Akova M, Akalin HE, Ascioglu S, Hayran M, Uzuns O, et al. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. Int J Antimicrob Agents. 2001;18(1):1–7.
Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Ben CT, et al. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis. 2007;11(5):430–3.
Bennis A, Zahraoui M, Azzouzi L, Soulami S, Mehadji BA, Tahiri A, et al. [Bacterial endocarditis in Morocco]. Ann Cardiol Angeiol (Paris). 1995;44(7):339–44.
Mirabel M, Rattanavong S, Frichitthavong K, Chu V, Kesone P, Thongsith P, et al. Infective endocarditis in the Lao PDR: clinical characteristics and outcomes in a developing country. Int J Cardiol. 2015;180:270–3.
Watt G, Lacroix A, Pachirat O, Baggett HC, Raoult D, Fournier PE, et al. Prospective comparison of infective endocarditis in Khon Kaen, Thailand and Rennes, France. Am J Trop Med Hyg. 2015;92(4):871–4.
El-Kholy AA, El-Rachidi NG, El-Enany MG, AbdulRahman EM, Mohamed RM, Rizk HH. Impact of serology and molecular methods on improving the microbiologic diagnosis of infective endocarditis in Egypt. Infection. 2015;43(5):523–9.
Tleyjeh IM, Abdel-Latif A, Rahbi H, Scott CG, Bailey KR, Steckelberg JM, et al. A systematic review of population-based studies of infective endocarditis. Chest. 2007;132(3):1025–35.
Rattanavong S, Fournier PE, Chu V, Frichitthavong K, Kesone P, Mayxay M, et al. Bartonella henselae endocarditis in Laos – ‘the unsought will go undetected’. PLoS Negl Trop Dis. 2014;8(12):e3385.
Lupis F, Giordano S, Pampinella D, Scarlata F, Romano A. Infective endocarditis: review of 36 cases. Infez Med. 2009;17(3):159–63.
Lamas CC, Ramos RG, Lopes GQ, Santos MS, Golebiovski WF, Weksler C, et al. Bartonella and Coxiella infective endocarditis in Brazil: molecular evidence from excised valves from a cardiac surgery referral center in Rio de Janeiro, Brazil, 1998 to 2009. Int J Infect Dis. 2013;17(1):e65–6.
Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62(7):584–92.
Zuily S, Regnault V, Selton-Suty C, Eschwege V, Bruntz JF, Bode-Dotto E, et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation. 2011;124(2):215–24.
Geri G, Wechsler B, Thi Huong DL, Isnard R, Piette JC, Amoura Z, et al. Spectrum of cardiac lesions in Behcet disease: a series of 52 patients and review of the literature. Medicine (Baltimore). 2012;91(1):25–34.
Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med. 1994;96(3):200–9.
Richet H, Casalta JP, Thuny F, Merrien J, Harle JR, Weiller PJ, et al. Development and assessment of a new early scoring system using non-specific clinical signs and biological results to identify children and adult patients with a high probability of infective endocarditis on admission. J Antimicrob Chemother. 2008;62(6):1434–40.
Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–413.
Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson Jr RB, et al. Executive summary: a guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis. 2013;57(4):485–8.
Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol. 1994;32(9):2103–6.
Wilson ML, Mirrett S, Reller LB, Weinstein MP, Reimer LG. Recovery of clinically important microorganisms from the BacT/Alert blood culture system does not require testing for seven days. Diagn Microbiol Infect Dis. 1993;16(1):31–4.
Fournier PE, Casalta JP, Habib G, Messana T, Raoult D. Modification of the diagnostic criteria proposed by the Duke Endocarditis Service to permit improved diagnosis of Q fever endocarditis. Am J Med. 1996;100(6):629–33.
Fournier PE, Mainardi JL, Raoult D. Value of microimmunofluorescence for diagnosis and follow-up of Bartonella endocarditis. Clin Diagn Lab Immunol. 2002;9(4):795–801.
Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177–207.
Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, et al. Diagnosis, management and outcome of Candida endocarditis. Clin Microbiol Infect. 2012;18(4):E99–109.
Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg. 2013;95(4):1467–74.
Vondracek M, Sartipy U, Aufwerber E, Julander I, Lindblom D, Westling K. 16S rDNA sequencing of valve tissue improves microbiological diagnosis in surgically treated patients with infective endocarditis. J Infect. 2011;62(6):472–8.
Marin M, Munoz P, Sanchez M, del Rosal M, Alcala L, Rodriguez-Creixems M, et al. Molecular diagnosis of infective endocarditis by real-time broad-range polymerase chain reaction (PCR) and sequencing directly from heart valve tissue. Medicine (Baltimore). 2007;86(4):195–202.
Fenollar F, Celard M, Lagier JC, Lepidi H, Fournier PE, Raoult D. Tropheryma whipplei endocarditis. Emerg Infect Dis. 2013;19(11):1721–30.
Mencacci A, Leli C, Montagna P, Cardaccia A, Meucci M, Bietolini C, et al. Diagnosis of infective endocarditis: comparison of the LightCycler SeptiFast real-time PCR with blood culture. J Med Microbiol. 2012;61(Pt 6):881–3.
Casalta JP, Thuny F, Fournier PE, Lepidi H, Habib G, Grisoli D, et al. DNA persistence and relapses questions on the treatment strategies of Enterococcus infections of prosthetic valves. PLoS One. 2012;7(12):e53335.
Casalta JP, Gouriet F, Roux V, Thuny F, Habib G, Raoult D. Evaluation of the LightCycler SeptiFast test in the rapid etiologic diagnosis of infectious endocarditis. Eur J Clin Microbiol Infect Dis. 2009;28:569–73.
Lepidi H, Coulibaly B, Casalta JP, Raoult D. Autoimmunohistochemistry: a new method for the histologic diagnosis of infective endocarditis. J Infect Dis. 2006;193(12):1711–7.
Thuny F, Gaubert JY, Jacquier A, Tessonnier L, Cammilleri S, Raoult D, et al. Imaging investigations in infective endocarditis: current approach and perspectives. Arch Cardiovasc Dis. 2013;106(1):52–62.
Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L, et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol. 2013;61(23):2374–82.
Gouriet F, Fournier PE, Zaratzian C, Sumian M, Cammilleri S, Riberi A, et al. Diagnosis of Bartonella henselae prosthetic valve endocarditis in man, France. Emerg Infect Dis. 2014;20(8):1396–7.
Jos SL, Angelakis E, Caus T, Raoult D. Positron emission tomography in the diagnosis of Whipple’s endocarditis: a case report. BMC Res Notes. 2015;8:56.
Gouriet F, Saby L, Delaunay E, Cammilleri S, Le DY, Riberi A, et al. Incidental diagnosis of colonic tumor by PET/CT in infectious endocarditis. J Infect. 2013;67(1):88–90.
Baddour LM, Wilson WR, Bayer AS, Fowler Jr VG, Bolger AF, Levison ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111(23):e394–434.
Raoult D, Houpikian P, Tissot DH, Riss JM, Arditi-Djiane J, Brouqui P. Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med. 1999;159(2):167–73.
Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis. 2001;33(3):312–6.
Million M, Walter G, Thuny F, Habib G, Raoult D. Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment. Clin Infect Dis. 2013;57(6):836–44.
Raoult D, Fournier PE, Vandenesch F, Mainardi JL, Eykyn SJ, Nash J, et al. Outcome and treatment of Bartonella endocarditis. Arch Intern Med. 2003;163:226–30.
Fenollar F, Rolain JM, Alric L, Papo T, Chauveheid MP, van Beek D, et al. Resistance to trimethoprim/sulfamethoxazole and Tropheryma whipplei. Int J Antimicrob Agents. 2009;34(3):255–9.
Cohen JL, Sloss LJ, Kundsin R, Golightly L. Prosthetic valve endocarditis caused by Mycoplasma hominis. Am J Med. 1989;86:819–21.
DiSesa VJ, Sloss LJ, Cohn LH. Heart transplantation for intractable prosthetic valve endocarditis. J Heart Transplant. 1990;9(2):142–3.
Fenollar F, Gauduchon V, Casalta JP, Lepidi H, Vandenesch F, Raoult D. Mycoplasma endocarditis: two case reports and a review. Clin Infect Dis. 2004;38(3):e21–4.
Jamil HA, Sandoe JA, Gascoyne-Binzi D, Chalker VJ, Simms AD, Munsch CM, et al. Late-onset prosthetic valve endocarditis caused by Mycoplasma hominis, diagnosed using broad-range bacterial PCR. J Med Microbiol. 2012;61(Pt 2):300–1.
Blasco M, Torres L, Marco ML, Moles B, Villuendas MC, Garcia Moya JB. Prosthetic valve endocarditis caused by Mycoplasma hominis. Eur J Clin Microbiol Infect Dis. 2000;19(8):638–40.
Dominguez SR, Littlehorn C, Nyquist AC. Mycoplasma hominis endocarditis in a child with a complex congenital heart defect. Pediatr Infect Dis J. 2006;25(9):851–2.
Hussain ST, Gordon SM, Tan CD, Smedira NG. Mycoplasma hominis prosthetic valve endocarditis: the value of molecular sequencing in cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(1):e7–9.
Scapini JP, Flynn LP, Sciacaluga S, Morales L, Cadario ME. Confirmed Mycoplasma pneumoniae endocarditis. Emerg Infect Dis. 2008;14(10):1664–5.
Kalokhe AS, Rouphael N, El Chami MF, Workowski KA, Ganesh G, Jacob JT. Aspergillus endocarditis: a review of the literature. Int J Infect Dis. 2010;14(12):e1040–7.
Scarano M, Pezzuoli F, Patane S. Brucella infective endocarditis. Int J Cardiol. 2014;172(3):e509–10.
Disclosure
P. Tattevin was supported financially by Abbott Laboratories, Astellas, AstraZeneca, Aventis, Bristol-Myers Squibb, Galderma, Gilead Sciences, Janssen-Cilag, MSD, Novartis, Pfizer, and the medicines company ViiV- Healthcare for research, for the organization of scientific meetings, trainings, and/or to attend national and international conferences.
C. Lamas was supported by Novartis Laboratories to attend national and international conferences.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Fournier, PE., Watt, G., Newton, P.N., Lamas, C.C., Tattevin, P., Raoult, D. (2016). Blood Culture-Negative Endocarditis. In: Habib, G. (eds) Infective Endocarditis. Springer, Cham. https://doi.org/10.1007/978-3-319-32432-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-32432-6_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32430-2
Online ISBN: 978-3-319-32432-6
eBook Packages: MedicineMedicine (R0)